Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$63.74 USD

63.74
9,888,884

+1.37 (2.20%)

Updated Jul 29, 2024 04:00 PM ET

After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Why Edwards Lifesciences (EW) Isn't Done Growing Earnings Yet

Edwards Lifesciences (EW) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

    Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

    Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene

      Kevin Cook headshot

      5 Healthcare Innovators I'm Still Buying

      When you think long-term about the megatrends in healthcare, it makes picking winners easier

        Edwards Lifesciences (EW) Tops Q1 Earnings, Updates '17 View

        Edwards Lifesciences Corp. (EW) reported first-quarter 2017 adjusted earnings per share (EPS) of 94 cents, which surpassed the Zacks Consensus Estimate by 14.6%.

          Medical Product Stocks Earnings on Apr 25: SYK, EW, LH

          Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.

            Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?

            Edward Lifesciences Corp. (EW) is scheduled to report first-quarter 2017 earnings results after market close on Apr 25.

              Tracey Ryniec headshot

              Should You Make a Bet on the Healthcare Stocks?

              The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.

                Why Is Edwards (EW) Up 4.1% Since the Last Earnings Report?

                Edwards (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  Swarup Gupta headshot

                  5 Biggest Winners from the Obamacare Replacement Bill Pushback

                  This setback was largely an outcome of the lack of consensus among various factions of the GOP.

                    Edwards Lifesciences (EW) Beats on Earnings & Sales in Q4

                    Edwards Lifesciences Corp. (EW) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%.

                      Edward Lifesciences (EW): What's in Store in Q4 Earnings?

                      Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.

                        Sheraz Mian headshot

                        The Clouds Will Lift After the Vote

                        The tightening of polls in recent days has added to uncertainty, but we will see a collective sigh of relief after a clear verdict.

                          Sheraz Mian headshot

                          Analyst Reports for Sprint, Eli Lilly, & United Technologies

                          Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), Sprint (S) and Eli Lilly (LLY).

                            4 Med Instrument Stocks for Q3 Earnings amid Election Chaos

                            The medical device sector is positioned for impressive growth in the near term.

                              Sheraz Mian headshot

                              The Uncertainty of a Close Election

                              The uncertainty of the tight election notwithstanding, stocks will rejoice as the results come in, irrespective of who the winner is.

                                Kevin Cook headshot

                                Bull of the Day: Edwards Lifesciences (EW)

                                Heart patients and investors around the world are grateful for this valve replacement technology

                                  MedTech Industry Stock Outlook - July 2016

                                  Two full quarters of 2016 are behind us and, while we await second quarter results over the coming weeks, we hardly expect a change in trend in the bullish MedTech sector.

                                    Kevin Cook headshot

                                    Bull of the Day: Edwards Lifesciences (EW)

                                    EW wins as more physicians are choosing minimally invasive heart procedures for their patients

                                      Jeremy Mullin headshot

                                      4 Stocks to Buy on Pullbacks

                                      The next market pullback will create opportunities to enter performing stocks.